Alyeska Investment Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-329,935
| Closed | -$20.8M | – | 728 |
|
|
2021
Q1 | $20.8M | Buy |
329,935
+106,126
| +47% | +$6.6M | 0.27% | 110 |
|
|
2020
Q4 | $13.9M | Buy |
+223,809
| New | +$13.8M | 0.2% | 161 |
|
|
2019
Q1 | – | Sell |
-320,454
| Closed | -$16M | – | 382 |
|
|
2018
Q4 | $16.7M | Buy |
+320,454
| New | +$17.2M | 0.24% | 128 |
|
|
2018
Q2 | – | Sell |
-998,032
| Closed | -$63.1M | – | 460 |
|
|
2018
Q1 | $63.1M | Buy |
998,032
+407,698
| +69% | +$26.2M | 0.52% | 71 |
|
|
2017
Q4 | $36.2M | Sell |
590,334
-573,008
| -49% | -$35.8M | 0.29% | 108 |
|
|
2017
Q3 | $74.2M | Sell |
1,163,342
-203,037
| -15% | -$11.9M | 0.55% | 58 |
|
|
2017
Q2 | $76.1M | Sell |
1,366,379
-109,045
| -7% | -$5.93M | 0.64% | 43 |
|
|
2017
Q1 | $80.2M | Buy |
+1,475,424
| New | +$80.9M | 0.65% | 41 |
|
|
2016
Q4 | – | Sell |
-347,555
| Closed | -$18.7M | – | 479 |
|
|
2016
Q3 | $18.7M | Sell |
347,555
-557,236
| -62% | -$35.8M | 0.17% | 193 |
|
|
2016
Q2 | $66.5M | Buy |
+904,791
| New | +$63.9M | 0.63% | 35 |
|
|
2015
Q3 | – | Sell |
-581,446
| Closed | -$38.7M | – | 472 |
|
|
2015
Q2 | $38.7M | Buy |
+581,446
| New | +$38.3M | 0.44% | 79 |
|
|
2014
Q3 | – | Sell |
-15,000
| Closed | -$728K | – | 389 |
|
|
2014
Q2 | $728K | Sell |
15,000
-152,362
| -91% | -$7.51M | 0.02% | 368 |
|
|
2014
Q1 | $8.69M | Sell |
167,362
-112,638
| -40% | -$5.99M | 0.24% | 154 |
|
|
2013
Q4 | $14.9M | Buy |
280,000
+5,000
| +2% | +$255K | 0.59% | 51 |
|
|
2013
Q3 | $12.7M | Buy |
275,000
+50,000
| +22% | +$2.19M | 0.52% | 66 |
|
|
2013
Q2 | $10.1M | Buy |
+225,000
| New | +$9.77M | 0.49% | 66 |
|
Other funds holding BMY
